- Home
- LYEL vs CIVB Comparison
LYEL vs CIVB Comparison
Compare LYEL & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LYEL | CIVB |
|---|---|---|
| Founded | 2018 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 466.8M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | LYEL | CIVB |
|---|---|---|
| Price | $19.89 | $22.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $27.25 | $26.00 |
| AVG Volume (30 Days) | ★ 83.6K | 68.1K |
| Earning Date | 03-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | N/A | ★ 31.34 |
| EPS | N/A | ★ 2.64 |
| Revenue | $36,000.00 | ★ $19,023,000.00 |
| Revenue This Year | N/A | $15.33 |
| Revenue Next Year | $17,438.13 | $6.44 |
| P/E Ratio | ★ N/A | $8.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $17.47 |
| 52 Week High | $45.00 | $25.59 |
Technical Indicators
Market Signals| Indicator | LYEL | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 40.46 | 43.73 |
| Support Level | $15.82 | $21.41 |
| Resistance Level | $27.30 | $22.69 |
| Average True Range (ATR) | 2.18 | 0.67 |
| MACD | -0.29 | 0.02 |
| Stochastic Oscillator | 27.78 | 41.90 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.